Sotyktu (deucravacitinib) for treatment of adults with active psoriatic arthritis (PsA). Sotyktu is an oral, selective ...
Key Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, ...
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...
Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, ...
5don MSN
Here's What To Do When Your Hair Products Suddenly Stop Working, According to Haircare Experts
Hint: The products themselves may not be the issue.
Allure on MSN
Oh God, there’s something called a “collagen cliff”
But there are ways for perimenopausal women to cushion the fall.
Discover how mandelic acid can support scalp health, remove buildup, and promote stronger, fuller hair. Experts share tips ...
The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.
Dual therapy with a GLP-1 receptor agonist plus ixekizumab demonstrates long-term benefits in psoriatic disease activity, ...
Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical ...
Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...
At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results